Related Experiment Video

Updated: Aug 8, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 15, 2011

[Therapy with cytokines and thymic factors in a complicated case of common variable immunodeficiency]

Alain R Rodríguez Orozco1

  • 1Laboratorio de Inmunología, División de Posgrado, Escuela de Medicina Ignacio Chávez, Universidad Michoacana, San Nicolás de Hidalgo. arorozco@hotmail.com

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|November 25, 2003
PubMed

Insights

This study reports a case of common variable immunodeficiency (CVID) with hyperprolactinemia, detailing immune responses to combined cytokine therapy. A combination of alpha 2 b-IFN, thymic factors, gammaglobulin, and GM-CSF proved effective for complicated CVID.

Area of Science:

  • Immunology
  • Clinical Medicine
  • Endocrinology

Background:

  • Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by impaired humoral immunity.
  • Hyperprolactinemia can exacerbate immune dysregulation and mucosal defense deficits.
  • Assessing immune responses in CVID patients with complex comorbidities is crucial for treatment optimization.

Observation:

  • A case of CVID presenting with hyperprolactinemia and severe mucosal damage was investigated.
  • Humoral and cellular immune responses were extensively evaluated.
  • The impact of cytokine therapy as an adjunct to conventional gammaglobulin treatment was analyzed.

Findings:

  • Combined therapy including alpha 2 b-interferon (IFN), thymic factors, gammaglobulin, and granulocyte-macrophage colony-stimulating factor (GM-CSF) demonstrated efficacy.
  • Long-term immune response monitoring correlated with therapeutic interventions.
  • This combination therapy was identified as a viable alternative for managing complicated CVID.

Implications:

  • The findings suggest a promising therapeutic strategy for complex CVID cases.
  • Understanding the interplay between hyperprolactinemia and CVID can inform future treatment protocols.
  • This study highlights the importance of personalized, combination therapies in managing primary immunodeficiencies.

More Related Videos

Isolation and Transplantation of Different Aged Murine Thymic Grafts.05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens06:03

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Published on: September 20, 2024

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...